Product Information
ALOGLIPTIN-METFORMIN 12.5-1000 is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $2.4891 per EA under NDC 45802021172. Its NADAC has been published 519 times since Jul 20, 2016.
Strength
12.5; 1000 mg/1; mg/1
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802021172
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA203414On Market Since
4/8/2016
Pharmacological Classes
Price Statistics
The NADAC for ALOGLIPTIN-METFORMIN 12.5-1000 has been published 519 times since Jul 20, 2016, and over the history we have for it it has declined 30.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.4891 per EA |
|---|---|
| All-time high | $3.5922 (Mar 15, 2017) |
| All-time low | $2.2473 (Oct 18, 2023) |
| 52-week high | $2.5444 |
| 52-week low | $2.2683 |
| Median price | $2.6690 |
| Average price | $2.6945 |
| Largest weekly change | +27.6% (Nov 22, 2023) |
| Weeks tracked | 519 |
| Tracking since | Jul 20, 2016 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ALOGLIPTIN-METFORMIN 12.5-1000?
The current National Average Drug Acquisition Cost (NADAC) for ALOGLIPTIN-METFORMIN 12.5-1000, manufactured by Padagis Israel Pharmaceuticals Ltd, is $2.4891 per EA (NDC 45802021172), effective Jun 24, 2026.
How has the price of ALOGLIPTIN-METFORMIN 12.5-1000 changed over time?
Over the history we have for it, the NADAC for ALOGLIPTIN-METFORMIN 12.5-1000 has declined 30.7%. It has been tracked across 519 weekly CMS publications since Jul 20, 2016.
What are the highest and lowest recorded NADAC prices for ALOGLIPTIN-METFORMIN 12.5-1000?
Since Jul 20, 2016, the NADAC for ALOGLIPTIN-METFORMIN 12.5-1000 has ranged from a low of $2.2473 (Oct 18, 2023) to a high of $3.5922 (Mar 15, 2017), with a median of $2.6690 per EA.
Are there cheaper alternatives to ALOGLIPTIN-METFORMIN 12.5-1000?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ALOGLIPTIN-METFORMIN 12.5-1000, but none are currently priced below it.
Who manufactures ALOGLIPTIN-METFORMIN 12.5-1000?
ALOGLIPTIN-METFORMIN 12.5-1000 (NDC 45802021172) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.
Related Drugs
Same classification